Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder

@article{Spencer2007EfficacyAS,
  title={Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder},
  author={T. Spencer and L. Adler and J. McGough and R. Muniz and Adult Adhd Research Group},
  journal={Biological Psychiatry},
  year={2007},
  volume={61},
  pages={1380-1387}
}
BACKGROUND This multicenter, randomized, fixed-dose, double-blind, placebo-controlled study evaluated efficacy of extended-release dexmethylphenidate (d-MPH-ER) in adults with attention-deficit/hyperactivity disorder (ADHD). METHODS Randomized adults with ADHD (n=221) received once-daily d-MPH-ER 20 mg, 30 mg, or 40 mg or placebo for 5 weeks. The primary efficacy variable was change from baseline to final visit in DSM-IV ADHD Rating Scale (ADHD-RS) total score. Secondary efficacy parameters… Expand
140 Citations
Long-Term Effectiveness and Safety of Dexmethylphenidate Extended-Release Capsules in Adult ADHD
  • 52
Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorder.
  • 15
Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD
  • M. Rösler, W. Retz, +6 authors R. Ammer
  • Psychology, Medicine
  • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2010
  • 105
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 26 REFERENCES
Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder.
  • 312
Analog classroom assessment of Adderall in children with ADHD.
  • 191
Pharmacokinetics and Clinical Effectiveness of Methylphenidate
  • 268
  • PDF
...
1
2
3
...